[1]
Russo, D., Afonso, M., Moreira, A., Mendonça, J. and Abreu, M. 2026. Targeting IDH1: Long-Term Efficacy and Tolerance of Ivosidenib in Advanced Chondrosarcoma. Acta Médica Portuguesa. (Sep. 2026). DOI:https://doi.org/10.20344/amp.24606.